Monographie - Docetaxel

Laatste update :
03/05/2024

Docetaxel

Molecuulstructuur

Merknamen in verschillende landen

Handelsnamen zijn slechts een indicatie; de samenstelling van hulpstoffen kan per land variëren afhankelijk van de fabrikant

Adenex	Colombia
Asodocel	Argentinië
Axogen	Chili
Bagotaxel	Chili
Bendadocel	Duitsland
Brecasta	Chili
Celtere	Peru
Daxotel	Chili, Colombia, Egypte, Maleisië
Doce NC	Duitsland
Docefrez	Indië, USA
Docekebir	Argentinië
Docetax	Iran, Venezuela
Docetaxin	Duitsland
Docewin	Marokko
Dolectran	Argentinië
Donataxel	Argentinië, Ecuador, Peru
Doxel	Turkije, Venezuela
Doxetal	Argentinië
Doxitax	Turkije
Oncodocel	Colombia, Peru
Onkotaxel	Colombia, Oostenrijk
Ribodocel	Duitsland
Santax	Turkije
Tadocel	Turkije
Taxceus	Groot Britannië
Taxotan	Duitsland
Taxotere	Argentinië, Australië, België, Canada, Chili, Colombia, Denemarken, Duitsland, Ecuador, Egypte, Finland, Frankrijk, Griekenland, Groot Britannië, Hongarije, IJsland, Iran, Italië, Japan, Kroatië, Luxemburg, Maleisië, Marokko, Mexico, Nederland, Nieuw Zeeland, Noorwegen, Oostenrijk, Polen, Portugal, Roemenië, Saudi-Arabië, Spanje, Thailand, Tunisie, Turkije, USA, Venezuela, Verenigde Arabische Emiraten, Zweden, Zwitserland
Texot	Argentinië
Tolnexa	Roemenië
Zenotere	Indië, Peru

Literatuur : Docetaxel

	Type	Publicatie
140	Artikel	Pearson SD, Trissel LA. Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components. Am J Hosp Pharm 1993 ; 50: 1405-1409.
250	Artikel	Mazzo DJ, Nguyen-Huu JJ, Pagniez S, Denis P. Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials. Am J Health-Syst Pharm 1997 ; 54: 566-569.
251	Artikel	Trissel LA, Gilbert DL, Martinez JF. Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
1423	Artikel	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1660	Artikel	Thiesen J, Krämer I. Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers. Pharm World Sci 1999 ; 21: 137-141.
1662	Artikel	Trissel LA, Saenz CA, Ingram DS, Ogundele AB. Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. J Oncol Pharm Practice 2002 ; 8: 33-37.
1754	Artikel	Trissel LA, Gilbert DL, Wolkin AC. Compatibility of docetaxel with selected drugs during simulated Y-site administration. Int J Pharm Compound 1999 ; 3: 241-244.
1940	Artikel	Xu QA, Trissel LA. Stability of palonosetron hydrochloride with paclitaxel and docetaxel during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 1596-1598.
1953	Artikel	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982	Artikel	Trissel LA, Ogundele AB. Compatibility of anidulafungin with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2005 ; 62: 834-837.
2175	Artikel	Dalle M, Sautou-Miranda V, Balayssac D, Bourlon S, Bagel S, Chopineau J. Peut-on conditionner les solutions de docétaxel dans des poches en PVC ? J Pharm Clin 2006 ; 25, 3: 147-152.
2210	Artikel	Walker S.E, Charbonneau F, Law S. Stability of Docetaxel Solution after Dilution in Ethanol and Storage in Vials and after Dilution in Normal Saline and Storage in Bags. Can J Hosp Pharm 2007 ; 60, 4: 231-237.
2262	Artikel	Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D. Compatibility of doripenem with other drugs during simulated Y-site administratioN Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2341	Poster	Bourlon S, Sautou-Miranda V, Dalle M. Release of di(2-ethylhexyl)phtalate from polyvinylchloride bags during docetaxel infusions Poster ESCP Stockholm May 2005
3130	Fabrikant	Docétaxel (Taxotere®) – Résumé des caractéristiques du produits Sanofi Avantis France 2009
3163	Artikel	Acott SR, Hart M. Physical and chemical stability of Taxotere 1-vial 20mg/mL infusion solution following refrigerated storage. EJHP 2010 ; 16, 5: 26-28.
3195	Artikel	MacLeod S, Sewell G. Physical and chemical stability of docetaxel infusions. EJHP 2011 ; 17, 2: 39-43.
3215	Artikel	Hart MC, Ahmed W. Taxotere 1-vial (docetaxel 20 mg/ml) physical and chemical stability over 28 days in infusion bags containing 0.9% saline solution and 5% glucose solution. EJOP 2011 ; 5,1: 24-27.
3277	Artikel	Yang Z, Cameron S, Paul H. Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration. Int J Pharm Compound 2012 ; 16, 1 : 82-85.
3804	Artikel	Lazzarini R, Salvadori S, Trapella C, Guerrini R, Marzola E, Pasini G, Dalpiaz A. Physicochemical stability of cabazitaxel and docetaxel solutions. EJHP 2014 ;22:150-155.
3937	Artikel	Park K.H, Chung D.J. Stability study of docetaxel solution (0.9% saline) using Non-PVC and PVC tubes for intravenous administration. Biomat Res 2015 ; 19, 2

Mentions Légales